MBRX Buy Disclosure
Foster Jonathan P. · SEC Form 4 · Filed Aug 5, 2026
Buy
Reported value range
Not reported
Foster Jonathan P. Chief Financial Officer
MBRX
Transaction date
Aug 3, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 2 days later
MBRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series I Warrants on Common Stock
- Quantity / price
- 879,999 shares
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001437749-26-025929
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moleculin Biotech, Inc. MBRX | Buy | Aug 3, 2026 | Not reported |
| Moleculin Biotech, Inc. MBRX Current | Buy | Aug 3, 2026 | Not reported |